Home Press Releases Vaping update: 2019 outbreak of lung disease associated with e-cigarettes

Vaping update: 2019 outbreak of lung disease associated with e-cigarettes

The update will include a brief introduction to e-cigarette product usage and associated exposures, an overview of the CDC response to the outbreak and CDC resources, lessons learned from sentinel case clusters reported from Wisconsin/Illinois and North Carolina and results of recent toxicological research identifying effects of e-cigarette exposures on pulmonary lipid homeostasis and innate immunity.

Background: In the summer of 2019, clinicians first recognized an outbreak of severe lung disease in users of e-cigarette products.  As of September 11, 2019, 380 cases had been identified across the United States in 36 states and one territory. 

Session Name: Update on the 2019 Outbreak of Lung Disease Associated with e-Cigarette Product Use (Vaping)
Date/Time: Sunday, October 20 from 10:45 a.m.- 11:45 a.m. CT
Location: CHEST Annual Meeting 2019
Room 386

Experts:

  • David Weissman, M.D, the National Institute for Occupational Safety and Health, Respiratory Health Division, will provide an overview of e-cigarette products, associated exposures and CDC response to the national outbreak.
  • Jennifer Layden, M.D, Illinois Department of Public Health, will share lessons learned from the outbreak of pulmonary illness related to e-cigarette use in Illinois and Wisconsin.
  • Kevin Davidson, M.D, WakeMed Health & Hospitals, will share lessons learned from the outbreak of e-cigarette-associated lipoid pneumonia in North Carolina.
  • Farrah Kheradmand, M.D, Baylor College of Medicine, will discuss the impact of e-cigarette use on pulmonary lipoid homeostasis and innate immunity.

Contact: Amy Jenkins
CHEST Press Room
Mobile +1 (312) 371-8365

CHEST 2019 is the 85th annual meeting for the American College of Chest Physicians held Oct. 19 to Oct. 23, 2019, in New Orleans. The American College of Chest Physicians, publisher of the journal CHEST®, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research and team-based care. Its mission is to champion the prevention, diagnosis and treatment of chest diseases through education, communication and research. It serves as an essential connection to clinical knowledge and resources for its 19,000 members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For more information about CHEST 2019, visit chestmeeting.chestnet.org, or follow CHEST meeting hashtag, #CHEST2019, on social media.